| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Research
1 company
Fairman Jeff is a VP, Research at Vaxcyte, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $14.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2022 | PCVX Vaxcyte, Inc. | VP, Research | Sell | 10,000 | $40.00 | $400,000.00 | -3.4% | +10.6% | +18.3% | |
| Oct 11, 2022 | PCVX Vaxcyte, Inc. | VP, Research | Sell | 5,000 | $25.50 | $127,500.00 | -1.7% | +84.3% | +93.0% | |
| Sep 6, 2022 | PCVX Vaxcyte, Inc. | VP, Research | Sell | 5,000 | $26.58 | $132,892.13 | -0.8% | +71.4% | +96.4% | |
| Aug 5, 2022 | PCVX Vaxcyte, Inc. | VP, Research | Sell | 15,000 | $25.57 | $383,507.50 | -2.4% | +72.8% | +91.5% | |
| May 20, 2022 | PCVX Vaxcyte, Inc. | VP, Research | Sell | 4,112 | $25.50 | $104,856.00 | -1.3% | -0.2% | +83.9% | |
| May 5, 2022 | PCVX Vaxcyte, Inc. | VP, Research | Sell | 888 | $25.80 | $22,914.40 | -0.3% | -0.3% | +109.3% | |
| Apr 5, 2022 | PCVX Vaxcyte, Inc. | VP, Research | Sell | 5,000 | $25.59 | $127,950.00 | -1.5% | -9.2% | +46.5% | |
| Mar 11, 2022 | PCVX Vaxcyte, Inc. | VP, Research | Sell | 10,000 | $25.50 | $255,000.00 | -2.9% | -21.7% | +55.7% | |
| Dec 27, 2021 | PCVX Vaxcyte, Inc. | VP, Research | Sale+OE | 4,750 | $23.60 | $112,092.50 | -27.5% | +2.0% | +96.7% | |
| Dec 16, 2021 | PCVX Vaxcyte, Inc. | VP, Research | Sale+OE | 4,619 | $22.50 | $103,927.50 | -42.9% | +23.8% | +115.8% |